Caroline Baumal
Chief Medical Officer · 4 filings · Latest: May 14, 2026
Apellis Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APLS | Caroline Baumal | Chief Medical Officer | Jan 22, 2026 | Sale | $21.77 | 2,797 | $60.9K | 86,527 | |
APLS | Baumal Caroline | — | Jan 22, 2026 | Proposed Sale | $21.77 | 2,797 | $60.9K | — | |
APLS | Caroline Baumal | Chief Medical Officer | Jan 20, 2026 | Sale | $19.79 | 1,882 | $37.3K | 89,324 | |
APLS | Baumal Caroline | — | Jan 20, 2026 | Proposed Sale | $19.79 | 1,882 | $37.3K | — | |
APLS | Baumal Caroline | — | Jan 5, 2026 | Proposed Sale | $25.53 | 3,020 | $77.1K | — | |
APLS | Baumal Caroline | — | Jan 17, 2025 | Proposed Sale | $29.96 | 1,853 | $55.5K | — | |
APLS | Baumal Caroline | — | Jan 6, 2025 | Proposed Sale | $33.81 | 2,816 | $95.2K | — |